Fresenius SE & Co. KGaA

  • WKN: 578560
  • ISIN: DE0005785604
  • Land: Deutschland

Nachricht vom 20.05.2022 | 17:10

DGAP-DD: Fresenius SE & Co. KGaA english


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
20.05.2022 / 17:09
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title: Dr.
First name: Sebastian
Last name(s): Biedenkopf

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
Fresenius SE & Co. KGaA

b) LEI
XDFJ0CYCOO1FXRFTQS51 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Financial instrument linked to a share or a debt instrument
ISIN: DE000A3MQQ17

b) Nature of the transaction
Granting of 7,536 subscription rights in connection with the implementation of the scrip dividend

c) Price(s) and volume(s)
Price(s) Volume(s)
0.00 EUR 0.00 EUR

d) Aggregated information
Price Aggregated volume
0.00 EUR 0.00 EUR

e) Date of the transaction
2022-05-17; UTC+2

f) Place of the transaction
Outside a trading venue



20.05.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

News im Fokus

Deutsche Post AG: Bekanntgabe gemäß Art. 5 Abs. 1 der Verordnung (EU) Nr. 596/2014 i.V.m. Art. 2 Abs. 1 der Del. VO (EU) 2016/1052 der Kommission (in der jeweils gültigen Fassung)

28. Juni 2022, 11:00

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

STEICO SE

Original-Research: STEICO SE (von Montega AG): Kaufen

28. Juni 2022